Literature DB >> 7666544

Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses.

R B Pepinsky1, I A Papayannopoulos, E P Chow, N K Krishna, R C Craven, V M Vogt.   

Abstract

The CA (capsid) protein of avian sarcoma and leukemia viruses occurs in multiple species. Only one form has been previously characterized biochemically. We have now determined that the mature CA protein of avian sarcoma and leukemia viruses exists as three species with different C termini, ending in amino acid residues A-476, A-478, and M-479 of the Gag precursor, respectively. These structures were deduced from a combination of cyanogen bromide peptide mapping, sequence analysis of tryptic peptides, and electrospray mass spectrometry. The three forms of CA were detected in the same ratios in Rous sarcoma virus and avian myeloblastosis virus and therefore are likely to represent a common feature of members of this genus of avian retroviruses. The only previously reported CA species, CAM-479, accounts for only about 36% of the total CA protein, while CAA-476 and CAA-478 account for 55 and 9%, respectively. From the analysis of peptides cleaved in vitro by PR, the viral protease, we infer that the cleavage site between A-476 and A-477 not only is recognized by PR but is the preferred site. We were unable to determine if A-478/A-479 is a cleavage site for PR or alternatively if CAA-478 results from further processing of CAM-479 by a carboxypeptidase. To study the biological significance of residues A-477 to M-479, we constructed genetically altered viruses in which deletions removed either residues 477 to 479 or 477 to 488. The resulting virus particles appeared to assembly with normal efficiencies, but the latter mutant showed slowed proteolytic processing. Neither of the mutants was infectious.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666544      PMCID: PMC189543     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  A nucleoprotein complex mediates the integration of retroviral DNA.

Authors:  B Bowerman; P O Brown; J M Bishop; H E Varmus
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

2.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

4.  Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.

Authors:  L E Henderson; R C Sowder; G W Smythers; S Oroszlan
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

5.  Structure and processing of the p2 region of avian sarcoma and leukemia virus gag precursor polyproteins.

Authors:  R B Pepinsky; R J Mattaliano; V M Vogt
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

6.  Fine-structure analyses of lipid-protein and protein-protein interactions of gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping.

Authors:  R B Pepinsky; V M Vogt
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

7.  Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Stromberg; N E Hurley; N L Davis; R R Rueckert; E Fleissner
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

8.  Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne).

Authors:  L E Henderson; R E Benveniste; R Sowder; T D Copeland; A M Schultz; S Oroszlan
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Differences in the pI heterogeneity of virion and intracellular Moloney murine leukaemia virus p30s.

Authors:  K Ikuta; R B Luftig
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

10.  Cyanogen bromide digestion of the avian myeloblastosis virus pp19 protein: isolation of an amino-terminal peptide that binds to viral RNA.

Authors:  S P Johnson; M Veigl; T Vanaman; J Leis
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

View more
  25 in total

1.  Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy.

Authors:  V M Vogt; M N Simon
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions.

Authors:  J B Bowzard; J W Wills; R C Craven
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Irregular and Semi-Regular Polyhedral Models for Rous Sarcoma Virus Cores.

Authors:  J Bernard Heymann; Carmen Butan; Dennis C Winkler; Rebecca C Craven; Alasdair C Steven
Journal:  Comput Math Methods Med       Date:  2008       Impact factor: 2.238

4.  Critical role of conserved hydrophobic residues within the major homology region in mature retroviral capsid assembly.

Authors:  John G Purdy; John M Flanagan; Ira J Ropson; Kristen E Rennoll-Bankert; Rebecca C Craven
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

5.  Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.

Authors:  Y Xiang; T W Ridky; N K Krishna; J Leis
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.

Authors:  M A Accola; S Höglund; H G Göttlinger
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.

Authors:  K Wiegers; G Rutter; H Kottler; U Tessmer; H Hohenberg; H G Kräusslich
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.

Authors:  G Schatz; I Pichova; V M Vogt
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.

Authors:  Karolína Bohmová; Romana Hadravová; Jitka Stokrová; Roman Tuma; Tomás Ruml; Iva Pichová; Michaela Rumlová
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release.

Authors:  Eva Gottwein; Jochen Bodem; Barbara Müller; Ariane Schmechel; Hanswalter Zentgraf; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.